Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Hilbe, W; Apfelbeck, U; Fridrik, M; Bernhart, M; Niessner, H; Abbrederis, K; Michlmayr, G; Pont, J; Linkesch, W; Hausmaninger, H; Arneitz, K; Baldinger, C; Duba, C; Eisterer, W; Greil, R; Konwalinka, G; Niederwieser, D; Gastl, G; Thaler, J.
Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.
LEUK RES. 1998; 22(10): 881-886.
Doi: 10.1016/S0145-2126(98)00064-2
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Linkesch Werner
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The present retrospective analysis is based on data of 213 patients with chronic myeloid leukaemia (CML). They were treated with interferon (IFN)alpha-2C (Berofor) at daily doses of 3.5 MU subcutaneously (s.c.), alone or in combination with low-dose ara-C or hydroxyurea, according to four consecutive studies of the Austrian CML Study Group. Comparisons were made between 41 patients aged > or = 60 years and 172 younger patients. The elderly patients (median: 64 years; range: 60-73) showed similar pretreatment characteristics compared with the younger group, but included a higher percentage of Sokal Stage three (51 vs 20%). Median observation periods were similar (38 vs 39 months), whereas the duration of IFNalpha treatment was shorter in the elderly group (median 57 vs 42 weeks). The rate of overall haematological responses (73 vs 78%) and complete haematological response (44 vs 54%), was similar in both cohorts. Differences seen in partial (5 vs 12%) and complete cytogenetic response (10 vs 13%), were not statistically significant, but a tendency in favour of the younger cohort had to be noted. Summing up, in elderly patients acceptable rates of haematological and cytogentic response can be expected after treatment with IFNalpha alone or in combination with LD ara-C or HU.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Aged -
- Antineoplastic Agents - adverse effects
- Antineoplastic Combined Chemotherapy Protocols - adverse effects
- Child - adverse effects
- Child, Preschool - adverse effects
- Cytarabine - administration and dosage
- Humans - administration and dosage
- Hydroxyurea - administration and dosage
- Interferon-alpha - adverse effects
- Leukemia, Myeloid, Chronic - drug therapy
- Middle Aged - drug therapy
- Retrospective Studies - drug therapy
- Survival Rate - drug therapy
- Find related publications in this database (Keywords)
- interferon-alpha
- LD ara-C
- CML
- side effects
- age